These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 14585525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Vitale C, Fini M, Leonardo F, Rossini P, Cerquetani E, Onorati D, Rosano GM.
    Maturitas; 2001 Dec 14; 40(3):239-45. PubMed ID: 11731185
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B, Rosselli M, Jaeger AW, Keller PJ, Dubey RK.
    J Clin Endocrinol Metab; 1997 Feb 14; 82(2):388-94. PubMed ID: 9024224
    [Abstract] [Full Text] [Related]

  • 5. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P, Dauzat M, Abramovici Y, Deklunder G, Body G, Crepin G, Denis A, Favier M.
    Gynecol Obstet Fertil; 2000 Feb 14; 28(7-8):509-17. PubMed ID: 10996962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index.
    Jackson S, Vyas S.
    Br J Obstet Gynaecol; 1998 Apr 14; 105(4):408-12. PubMed ID: 9609267
    [Abstract] [Full Text] [Related]

  • 10. The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women.
    Ozsener S, Sağol S, Oztekin K, Bilgin O.
    Int J Gynaecol Obstet; 2000 Jun 14; 69(3):281-2. PubMed ID: 10854874
    [No Abstract] [Full Text] [Related]

  • 11. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study.
    Penotti M, Farina M, Castiglioni E, Gaffuri B, Barletta L, Gabrielli L, Vignali M.
    Am J Obstet Gynecol; 1996 Sep 14; 175(3 Pt 1):606-11. PubMed ID: 8828422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study.
    Huang CY, Fu CY, Tseng JY, Yang TS, Chao KC.
    Taiwan J Obstet Gynecol; 2009 Mar 14; 48(1):60-4. PubMed ID: 19346194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S, Kirilov G, Kalinov K, Shigarminova R, Nachev E, Orbetzova M, Atanassova I.
    Gynecol Endocrinol; 2002 Dec 14; 16(6):461-7. PubMed ID: 12626033
    [Abstract] [Full Text] [Related]

  • 16. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R, Urdinola J, Onatra W, Sánchez F, Posso H.
    Maturitas; 1999 May 31; 32(1):41-50. PubMed ID: 10423715
    [Abstract] [Full Text] [Related]

  • 17. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C.
    Am J Med; 1991 May 31; 90(5):584-9. PubMed ID: 1827568
    [Abstract] [Full Text] [Related]

  • 18. The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study.
    Penotti M, Sironi L, Miglierina L, Farina M, Barletta L, Gabrielli L, Vignali M.
    Am J Obstet Gynecol; 1998 Apr 31; 178(4):801-5. PubMed ID: 9579448
    [Abstract] [Full Text] [Related]

  • 19. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
    Tuppurainen M, Heikkinen AM, Penttilä I, Saarikoski S.
    Maturitas; 1995 Jun 31; 22(1):55-61. PubMed ID: 7666817
    [Abstract] [Full Text] [Related]

  • 20. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy.
    Luckas MJ, Gleeve T, Biljan MM, Buckett WM, Aird IA, Drakeley A, Kingsland CR.
    Eur J Obstet Gynecol Reprod Biol; 1998 Feb 31; 76(2):221-4. PubMed ID: 9481579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.